Agile Therapeutics
AGRX
#10911
Rank
C$14.93 M
Marketcap
C$2.16
Share price
0.00%
Change (1 day)
329.78%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -C$20.4 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are C$21.56 Million. In 2023 the company made an earning of -C$18.7 Million a decrease over its 2022 earnings that were of -C$6.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$20.4 Million9.07%
2023 -C$18.7 Million172.57%
2022 -C$6.86 Million-93.26%
2021 -C$0.11 Billion45.62%
2020 -C$69.85 Million161.98%
2019 -C$26.67 Million-2.78%
2018 -C$27.43 Million-27.47%
2017 -C$37.82 Million-10.16%
2016 -C$42.09 Million-14.2%
2015 -C$49.06 Million88.45%
2014 -C$26.03 Million41.72%
2013 -C$18.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.82 B-124,690.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.98 B-46,472.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.63 B-44,842.45%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
C$0.16 M-100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$94.4 M-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA